| Stephan Hatch, MD | |
|
365 Montauk Ave, Anesthesia Department, New London, CT 06320 | |
| (860) 442-0711 | |
| (860) 443-4458 |
| Full Name | Stephan Hatch |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 23 Years |
| Location | 365 Montauk Ave, New London, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144277609 | NPI | - | NPPES |
| 1144277609 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 24180 (New York) | Secondary |
| 207L00000X | Anesthesiology | 042.0012965 (Vermont) | Secondary |
| 207L00000X | Anesthesiology | 234074 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jjm Medical Services Pc | 6800950312 | 54 |
| Jjm Medical Services Pc | 6800950312 | 54 |
News Archive
Cipher Pharmaceuticals Inc. (NASDAQ: CPHR; TSX:CPH) ("Cipher" or "the Company") today announced that the Beteflam Patch (previously called the Betesil® Patch) has been accepted for review by Health Canada.
An innovative model of dementia care developed by researchers at the Indiana University School of Medicine and the Regenstrief Institute significantly reduces emergency department visits and hospitalizations, and encourages use of medications that are not harmful to older brains. The result is improved health for older adults and their family caregivers and lower healthcare costs, according to a paper evaluating the model in real world use.
Senators working feverishly to pass health reform ahead of Congress' August recess raised doubts Wednesday on whether they will be able to pass reform on schedule, The Boston Globe reports.
Ovatech, an emerging women's health-focused company, announced today that the Company's Phase 2 clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has been successfully completed. Ovaprene is a 'one-size-fits-all' patented, female-controlled, intravaginal organic silicone ring barrier-contraceptive that is designed to continuously release spermiostatic and spermicidal non-drug agents over a four-week period.
Exosomes are natural nanoscopic particles released by most cell types, and are currently the focus of research because they represent a possible tool for the diagnosis of Alzheimer's. These particles are not so easy to isolate, and nanotechnology may help in this process.
› Verified 1 days ago
| Entity Name | Beverly Anesthesia Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427041268 PECOS PAC ID: 2961491667 Enrollment ID: O20040508000009 |
News Archive
Cipher Pharmaceuticals Inc. (NASDAQ: CPHR; TSX:CPH) ("Cipher" or "the Company") today announced that the Beteflam Patch (previously called the Betesil® Patch) has been accepted for review by Health Canada.
An innovative model of dementia care developed by researchers at the Indiana University School of Medicine and the Regenstrief Institute significantly reduces emergency department visits and hospitalizations, and encourages use of medications that are not harmful to older brains. The result is improved health for older adults and their family caregivers and lower healthcare costs, according to a paper evaluating the model in real world use.
Senators working feverishly to pass health reform ahead of Congress' August recess raised doubts Wednesday on whether they will be able to pass reform on schedule, The Boston Globe reports.
Ovatech, an emerging women's health-focused company, announced today that the Company's Phase 2 clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has been successfully completed. Ovaprene is a 'one-size-fits-all' patented, female-controlled, intravaginal organic silicone ring barrier-contraceptive that is designed to continuously release spermiostatic and spermicidal non-drug agents over a four-week period.
Exosomes are natural nanoscopic particles released by most cell types, and are currently the focus of research because they represent a possible tool for the diagnosis of Alzheimer's. These particles are not so easy to isolate, and nanotechnology may help in this process.
› Verified 1 days ago
| Entity Name | Jjm Medical Services Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952548265 PECOS PAC ID: 6800950312 Enrollment ID: O20090128000435 |
News Archive
Cipher Pharmaceuticals Inc. (NASDAQ: CPHR; TSX:CPH) ("Cipher" or "the Company") today announced that the Beteflam Patch (previously called the Betesil® Patch) has been accepted for review by Health Canada.
An innovative model of dementia care developed by researchers at the Indiana University School of Medicine and the Regenstrief Institute significantly reduces emergency department visits and hospitalizations, and encourages use of medications that are not harmful to older brains. The result is improved health for older adults and their family caregivers and lower healthcare costs, according to a paper evaluating the model in real world use.
Senators working feverishly to pass health reform ahead of Congress' August recess raised doubts Wednesday on whether they will be able to pass reform on schedule, The Boston Globe reports.
Ovatech, an emerging women's health-focused company, announced today that the Company's Phase 2 clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has been successfully completed. Ovaprene is a 'one-size-fits-all' patented, female-controlled, intravaginal organic silicone ring barrier-contraceptive that is designed to continuously release spermiostatic and spermicidal non-drug agents over a four-week period.
Exosomes are natural nanoscopic particles released by most cell types, and are currently the focus of research because they represent a possible tool for the diagnosis of Alzheimer's. These particles are not so easy to isolate, and nanotechnology may help in this process.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephan Hatch, MD Po Box 1849, Lewiston, ME 04241-1849 Ph: (207) 777-1439 | Stephan Hatch, MD 365 Montauk Ave, Anesthesia Department, New London, CT 06320 Ph: (860) 442-0711 |
News Archive
Cipher Pharmaceuticals Inc. (NASDAQ: CPHR; TSX:CPH) ("Cipher" or "the Company") today announced that the Beteflam Patch (previously called the Betesil® Patch) has been accepted for review by Health Canada.
An innovative model of dementia care developed by researchers at the Indiana University School of Medicine and the Regenstrief Institute significantly reduces emergency department visits and hospitalizations, and encourages use of medications that are not harmful to older brains. The result is improved health for older adults and their family caregivers and lower healthcare costs, according to a paper evaluating the model in real world use.
Senators working feverishly to pass health reform ahead of Congress' August recess raised doubts Wednesday on whether they will be able to pass reform on schedule, The Boston Globe reports.
Ovatech, an emerging women's health-focused company, announced today that the Company's Phase 2 clinical study of its non-hormonal, intravaginal contraceptive ring, Ovaprene, has been successfully completed. Ovaprene is a 'one-size-fits-all' patented, female-controlled, intravaginal organic silicone ring barrier-contraceptive that is designed to continuously release spermiostatic and spermicidal non-drug agents over a four-week period.
Exosomes are natural nanoscopic particles released by most cell types, and are currently the focus of research because they represent a possible tool for the diagnosis of Alzheimer's. These particles are not so easy to isolate, and nanotechnology may help in this process.
› Verified 1 days ago
Eric Balch, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 365 Montauk Ave, Anesthesia Department, New London, CT 06320 Phone: 860-442-0711 Fax: 860-443-4458 | |
Curt Wilson Gramlich, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-442-0711 Fax: 401-348-3792 | |
Dr. Nicholas Matthew Lodato, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 365 Montauk Ave, Anesthesia Associates Of New London, New London, CT 06320 Phone: 860-442-0711 | |
William M Junior, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-442-0711 Fax: 434-982-0019 | |
Jean Duross Turner, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-442-0711 | |
Dr. Amy Wen-mcgovern, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 365 Montauk Ave, New London, CT 06320 Phone: 860-442-0711 |